30 Apr 2013
Health Meeting
Senate Capitol Building
12:00 PM to 12:11 PM Archived Video
Senate Standing Committee on Health
Senator Kemp Hannon, Chair
12 Noon, Tuesday, April 30, 2013
Room 123 CAP
PLEASE NOTE: The following bills have been placed on the agenda pursuant to Senate Rule VII, §3(e) - Motion for Committee Consideration:
S.2066
Printed No. | Sponsor | Title |
270 | Larkin | An act to amend the public health law, in relation to requiring facilities to perform pulse oximetry screening on newborns |
2066 | Latimer | An act to amend the public health law, in relation to investigations of professional medical conduct |
Young | An act to amend the public health law, in relation to expanding the Doctors Across New York program to include dentists | |
Golden | An act to amend the public health law, in relation to sales and purchases of human organs | |
2439 | Klein | An act to amend the public health law, in relation to the inclusion of weight control in the health care and wellness education and outreach program; and to amend the insurance law, in relation to wellness programs |
2750 | Hannon | An act to amend the public health law, in relation to requiring hospitals to offer hepatitis C testing |
3768 | Hannon | An act to amend the public health law, in relation to breast cancer research |
Hannon | An act to amend the public health law, in relation to patient notice of the provision of observation services | |
3947 | Grisanti | An act to amend the public health law, in relation to regulating heavy metals, magnets and batteries in children's jewelry; and providing for the repeal of such provisions upon expiration thereof |
Perkins | An act to amend chapter 192 of the laws of 2011, relating to authorizing certain health care professionals licensed to practice in other jurisdictions to practice in this state in connection with an event sanctioned by New York Road Runners, in relation to extending the provisions thereof | |
Hannon | An act to amend the public health law, in relation to designating Carbapenem-resistant Enterobacteriaceae (CRE) as a communicable disease and requiring general hospitals to identify and track the incidence of such communicable disease in accordance with the hospital acquired infection reporting system |